a76df2f9_docrine_Cancer_Research___CFCF__Status
[Title] A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors [Phase] II [Conditions] Pancreatic Neuroendocrine Tumor [State] CA FL [Status] 
Enrolling
N o t R e c r u i t i n g
E n r o l l i n g
Clinical Trials Finder | Carcinoid and Pancreatic Neuroendocrine Cancer Research | CFCF
Status